EUVIMEDEUVIMED entdecken
Multizentrische Studie

Review and standard operating procedures for collection of biospecimens and analysis of biomarkers in new onset refractory status epilepticus

Aurélie Hanin iD, Jorge Cespedes, Yashwanth Pulluru, Margaret Gopaul, Eleonora Aronica, Danielle Decampo, Ingo Helbig iD, Charles L Howe iD, Anita Huttner, Sookyong Koh, Vincent Navarro iD, Olga Taraschenko iD und 5 weitere

Epilepsia · 2023

DOI: 10.1111/epi.17600 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Epilepsia, 2023. Verfasst von Aurélie Hanin und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology and Immunobiology, Yale University School of Medicine, New Haven, Connecticut, USA. Hauptthemen laut MEDLINE: Status Epilepticus, Drug Resistant Epilepsy, Encephalitis. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 74 Literaturangaben. Gefördert von: NINDS NIH HHS, NCATS NIH HHS, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

New onset refractory status epilepticus (NORSE), including its subtype with a preceding febrile illness known as febrile infection‐related epilepsy syndrome (FIRES), is one of the most severe forms of status epilepticus. The exact causes of NORSE are currently unknown, and there is so far no disease‐specific therapy. Identifying the underlying pathophysiology and discovering specific biomarkers, whether immunologic, infectious, genetic, or other, may help physicians in the management of patients with NORSE. A broad spectrum of biomarkers has been proposed for status epilepticus patients, some of which were evaluated for patients with NORSE. Nonetheless, none has been validated, due to significant variabilities in study cohorts, collected biospecimens, applied analytical methods, and defined outcome endpoints, and to small sample sizes. The NORSE Institute established an open NORSE/FIRES biorepository for health‐related data and biological samples allowing the collection of biospecimens worldwide, promoting multicenter research and sharing of data and specimens. Here, we suggest standard operating procedures for biospecimen collection and biobanking in this rare condition. We also propose criteria for the appropriate use of previously collected biospecimens. We predict that the widespread use of standardized procedures will reduce heterogeneity, facilitate the future identification of validated biomarkers for NORSE, and provide a better understanding of the pathophysiology and best clinical management for these patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Status EpilepticusDrug Resistant EpilepsyEncephalitisHumansBiological Specimen BanksSeizuresBiomarkers

Stichwörter der Autor:innen

biomarkersbiospecimensnew onset refractory status epilepticusstandard operating procedures

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Department of Neurology and Immunobiology, Yale University School of Medicine, New Haven, Connecticut, USA.
  • Sorbonne Université, Institut du Cerveau ICM, Paris Brain Institute, Inserm, CNRS, Assistance Publique - Hôpitaux de Paris, Hôpital de la Pitié-Salpêtrière, DMU Neurosciences 6, Paris, France.
  • Assistance Publique - Hôpitaux de Paris, Hôpital de la Pitié-Salpêtrière, DMU Neurosciences 6, Epilepsy Unit and Department of Clinical Neurophysiology, Paris, France.
  • Comprehensive Epilepsy Center, Department of Neurology, Yale University School of Medicine, New Haven, Connecticut, USA.
  • Universidad Autonoma de Centro America, School of Medicine, San Jose, Costa Rica.
  • Nebraska Medical Center, Omaha, Nebraska, USA.

ORCID-Profile: Aurélie Hanin, Ingo Helbig, Charles L Howe, Vincent Navarro, Olga Taraschenko, Annamaria Vezzani, Nicolas Gaspard, Lawrence J Hirsch

Förderung

  • NINDS NIH HHS
  • NCATS NIH HHS
  • NIGMS NIH HHS
  • Philippe Foundation

Zitieren

APA

Hanin, A., Cespedes, J., Pulluru, Y., Gopaul, M., Aronica, E., Decampo, D., Helbig, I., Howe, C. L., Huttner, A., Koh, S., Navarro, V., Taraschenko, O., Vezzani, A., Wilson, M. R., Xian, J., Gaspard, N., & Hirsch, L. J. (2023). Review and standard operating procedures for collection of biospecimens and analysis of biomarkers in new onset refractory status epilepticus. Epilepsia. https://doi.org/10.1111/epi.17600

Vancouver

Hanin A, Cespedes J, Pulluru Y, Gopaul M, Aronica E, Decampo D, et al. Review and standard operating procedures for collection of biospecimens and analysis of biomarkers in new onset refractory status epilepticus. Epilepsia. 2023. doi:10.1111/epi.17600

BibTeX
@article{Hanin2023,
  author = {Hanin, Aurélie and Cespedes, Jorge and Pulluru, Yashwanth and Gopaul, Margaret and Aronica, Eleonora and Decampo, Danielle and Helbig, Ingo and Howe, Charles L and Huttner, Anita and Koh, Sookyong and Navarro, Vincent and Taraschenko, Olga and Vezzani, Annamaria and Wilson, Michael R and Xian, Julie and Gaspard, Nicolas and Hirsch, Lawrence J},
  title = {Review and standard operating procedures for collection of biospecimens and analysis of biomarkers in new onset refractory status epilepticus},
  journal = {Epilepsia},
  year = {2023},
  doi = {10.1111/epi.17600}
}
Kostenlos starten →